Optimizing molecular residual disease detection using liquid biopsy postoperatively in early stage lung cancer.

Lung Cancer Manag

Department of Pathology and Laboratory Medicine, BC Cancer, Cancer Genetics & Genomics Laboratory, Vancouver, BC, Canada.

Published: February 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186850PMC
http://dx.doi.org/10.2217/lmt-2019-0017DOI Listing

Publication Analysis

Top Keywords

optimizing molecular
4
molecular residual
4
residual disease
4
disease detection
4
detection liquid
4
liquid biopsy
4
biopsy postoperatively
4
postoperatively early
4
early stage
4
stage lung
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!